Cancer Research Cancer Epigenetics  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 2341-2346, April 15, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vatten, L. J.
Right arrow Articles by Foss, O. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vatten, L. J.
Right arrow Articles by Foss, O. P.

Total Serum Cholesterol and Triglycerides and Risk of Breast Cancer: A Prospective Study of 24,329 Norwegian Women1

Lars J. Vatten2 and Olav P. Foss

Department of Oncology, University Hospital, N-7006 Trondheim [L. J. V.]; The Norwegian Cancer Registry Montebello, N-0310 Oslo 3 [L. J. V.]; and Central Laboratory, Ullevaal Hospital, N-0407 Oslo 4 [O. P. F.], Norway

The association between total serum cholesterol and triglycerides and the incidence rate of breast cancer has been examined in 242 incident cases of breast cancer that developed among 24,329 Norwegian women during 11–14 years of follow-up. At the time of lipid measurement they were between 35 and 51 years of age.

There was an inverse relation between serum cholesterol and risk of breast cancer which was confined to women diagnosed before the age of 51. The incidence rate ratio was 0.53 (95% confidence limits, 0.32 and 0.88) for women in the highest quartile of serum cholesterol (mean = 8.52 mM = 329 mg/100 ml) compared to women in the lowest quartile (mean = 5.28 mM = 204 mg/100 ml), and the relation displayed a negative trend over quartiles of cholesterol (x2 for trend = 3.94, P = 0.05). No association with cholesterol was found among cases diagnosed during the initial 2 years of follow-up, whereas a strong inverse relation was observed among cases that were diagnosed during the following 4 years (x2 trend = 12.6, P < 0.001).

For serum triglycerides there was an overall negative, but not statistically significant, association with breast cancer incidence, which was weakened after further adjustment for body mass index and serum cholesterol. The lack of information on reproductive factors associated with breast cancer risk is a limitation of this study, since potential confounding with the results cannot be excluded.

We conclude that there is an inverse relation between serum cholesterol and breast cancer risk among women diagnosed before the age of 51 years. The findings indicate that the negative association cannot easily be attributed to a preclinical effect of the cancer.

1 This research is based on data made available by The National Health Screening Service and The Cancer Registry of Norway.

2 Research fellow of The Norwegian Cancer Society. To whom requests for reprints should be addressed, at Department of Oncology, University Hospital, N-7006 Trondheim, Norway.

Received 8/31/89. Revised 12/21/89.


This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
X. Yang, W.-Y. So, R. C W Ma, G. T C Ko, A. P S Kong, Q. Wang, C. S Cockram, C.-C. Chow, J. C N Chan, and P. C Y Tong
Predicting values of lipids and white blood cell count for all-site cancer in type 2 diabetes
Endocr. Relat. Cancer, June 1, 2008; 15(2): 597 - 607.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
F. Xue and K. B Michels
Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 823S - 835S.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
A. H. Eliassen, G. A. Colditz, B. Rosner, W. C. Willett, and S. E. Hankinson
Serum Lipids, Lipid-Lowering Drugs, and the Risk of Breast Cancer
Arch Intern Med, October 24, 2005; 165(19): 2264 - 2271.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. M. Ward, P. Schulte, B. Grajewski, A. Andersen, D. G. Patterson Jr., W. Turner, E. Jellum, J. A. Deddens, J. Friedland, N. Roeleveld, et al.
Serum Organochlorine Levels and Breast Cancer: A Nested Case-Control Study of Norwegian Women
Cancer Epidemiol. Biomarkers Prev., December 1, 2000; 9(12): 1357 - 1367.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.